Comparative Evaluation of the Chemical Components and Anti-Inflammatory Potential of Yellow- and Blue-Flowered Meconopsis Species: M. integrifolia and M. betonicifolia
Open Access
- 20 October 2024
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 14 (10) , 563
Abstract
Background/Objectives: Meconopsis has long been used in traditional Tibetan medicine to treat various inflammatory and pain-related conditions. However, blue-flowered Meconopsis (M. betonicifolia) is becoming increasingly scarce due to overharvesting. As a potential alternative, yellow-flowered Meconopsis (M. integrifolia) shows promise but requires comprehensive characterization. This study aimed to evaluate and compare the anti-inflammatory potential of yellow- and blue-flowered Meconopsis species. Methods: Liquid chromatography–mass spectrometry (LC-MS) techniques were used to analyze the chemical profiles of yellow- and blue-flowered Meconopsis. Putative targets of shared constituents were subjected to GO and disease enrichment analysis. The LPS-induced RAW264.7 macrophage model was employed to assess anti-inflammatory effects. Metabolomics was applied to gain mechanistic insights. Results: LC-MS revealed over 70% chemical similarity between species. Enrichment analysis associated targets with inflammation-related pathways. In macrophage assays, both species demonstrated dose-dependent antioxidative and anti-inflammatory activities, with yellow Meconopsis exhibiting superior efficacy. Metabolomics showed modulation of key inflammatory metabolic pathways. Conclusions: This integrative study validated yellow-flowered Meconopsis as a credible alternative to its blue-flowered counterpart for anti-inflammatory applications. Metabolic profiling provided initial clues regarding their multi-targeted modes of action, highlighting their potential for sustainable utilization and biodiversity conservation.Keywords
All Related Versions
Funding Information
- Key Research and Development Plan of Tibet Autonomous Region, China (XZ202101ZY0013G)
- State-owned Assets Supervision and Administration Commission of the People’s Government of Tibet Autonomous Region (XZ202101ZY0013G)
This publication has 48 references indexed in Scilit:
- Proline metabolism and redox; maintaining a balance in health and diseaseAmino Acids, 2021
- Arginine-dependent immune responsesCellular and Molecular Life Sciences, 2021
- Effects of different branched-chain amino acids supplementation protocols on the inflammatory response of LPS-stimulated RAW 264.7 macrophagesAmino Acids, 2021
- The fate of Meconopsis species in the Tibeto‐Himalayan region under future climate changeEcology and Evolution, 2020
- Upward elevation and northwest range shifts for alpine Meconopsis species in the Himalaya–Hengduan Mountains regionEcology and Evolution, 2019
- Manipulating macrophage polarization and function using classical HDAC inhibitors: Implications for autoimmunity and inflammationCritical Reviews in Oncology/Hematology, 2018
- Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory ProcessesEuropean Journal of Pharmacology, 2016
- Mass spectrometry‐based metabolomics: applications to biomarker and metabolic pathway researchBiomedical Chromatography, 2015
- Methionine Inhibits Autophagy and Promotes Growth by Inducing the SAM-Responsive Methylation of PP2ACell, 2013
- The arachidonic acid cascadeInflammation, 1984